It has also been demonstrated in the treatment of hypoxia and anemia in a newborn rat model, that the effect of treatment with EPO nanoparticles is 10 times greater compared with regular EPO treatment (8), suggesting that nanotechnology with EPO delivery is able to significantly enhance its therapeutic effects. This evidence concerns the gene EPO and anemia.